Results 211 to 220 of about 37,459 (257)

Intestinal and multiple organ transplantation [PDF]

open access: yes, 2000
Abu-Elmagd, K   +6 more
core  

Cytomegalovirus-associated CD57 + KLRG1 + CD8 + TEMRA T cells are associated with reduced risk of CMV viremia in kidney transplantation and chronic allograft dysfunction in lung transplantation

open access: hybrid
Harry Pickering   +14 more
openalex   +1 more source

Humoral immunity to lung antigens early post-transplant confers risk for chronic lung allograft dysfunction

open access: hybrid
Daniel Vosoughi   +10 more
openalex   +1 more source

CD26/DPP-IV Inhibitors and Associations with Chronic Lung Allograft Dysfunction in a Multicenter Cohort

open access: hybrid
A. Graham   +15 more
openalex   +1 more source

Chronic lung allograft dysfunction after lung transplantation - prevention, diagnosis and treatment in 44 European centers

open access: gold
Jens Gottlieb   +40 more
openalex   +1 more source

The diagnosis and management of chronic lung allograft dysfunction

open access: yesCurrent Opinion in Pulmonary Medicine
Purpose of review Chronic lung allograft dysfunction (CLAD) remains a life-threatening complication following lung transplantation. Different CLAD phenotypes have recently been defined, based on the combination of pulmonary function testing and chest ...
G. Verleden   +2 more
semanticscholar   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Surgical therapy of chronic lung allograft dysfunction

Perspectives in Surgery, 2023
Lung transplantation has become a standardized and widely accepted treatment modality for selected end-stage lung diseases. Many factors influence the long-term survival of patients after lung transplantation. One of the most important is clearly the development of chronic lung allograft dysfunction (CLAD).
R, Novysedlák   +5 more
openaire   +2 more sources

Emerging biomarkers in chronic lung allograft dysfunction

Expert Review of Molecular Diagnostics, 2020
Introduction: Lung transplantation remains an important treatment for patients with end stage lung disease. Chronic lung allograft dysfunction (CLAD) remains the greatest limiting factor for long term survival. As the diagnosis of CLAD is based on pulmonary function tests, significant lung injury is required before a diagnosis is feasible, likely when ...
Joshua M. Diamond   +2 more
openaire   +3 more sources

Update in Chronic Lung Allograft Dysfunction

Clinics in Chest Medicine, 2017
Chronic lung allograft dysfunction (CLAD) is the major limitation to posttransplant survival. This review highlights the evolving definition of CLAD, risk factors, treatment, and expected outcomes after the development of CLAD.
Rupal J. Shah, Joshua M. Diamond
openaire   +3 more sources

Chronic lung allograft dysfunction

Current Respiratory Care Reports, 2014
The recognition that chronic graft dysfunction after lung transplantation is a heterogeneous phenomenon has led to the introduction of a new term: chronic lung allograft dysfunction (CLAD). An International Society for Heart and Lung Transplantation working group will determine a definition of CLAD in 2014.
Masaaki Sato, Masaaki Sato
openaire   +2 more sources

Home - About - Disclaimer - Privacy